You are here

Article info

Article menu
Download PDFPDF
Editorial
Niacin—a case study for the role of event-driven versus surrogate endpoint trials

Authors

  1. Correspondence to Dr Michael J Blaha, Department of Medicine/Cardiology, The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Carnegie 565A, JHH, 600 N. Wolfe St., Baltimore, MD 21287, USA; mblaha1{at}jhmi.edu
View Full Text

Citation

Blaha MJ, Michos ED
Niacin—a case study for the role of event-driven versus surrogate endpoint trials
Heart 2013;99:1631-1632.

Publication history

  • First published September 16, 2013.
Online issue publication 
October 16, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions